The antitumor effects were particularly pronounced within the ssRNA-4-1BBL and ssRNA-OX40L groups, with complete tumor regression observed in one of nine mice in the ssRNA-4-1BBL-treated group and two of nine mice in the ssRNA-OX40L-treated group. The gene discussed is TNFSF4; the disease is neoplasm.